EpiPen Nasal Spray Suffers Setback as FDA Seeks Fresh Study EpiPen Nasal Spray Suffers Setback as FDA Seeks Fresh Study
The regulator has declined to approve a nasal spray that would have been the first needle-free emergency treatment for allergic reactions.Reuters Health Information
Source: Medscape Allergy Headlines - September 20, 2023 Category: Allergy & Immunology Tags: Pediatrics News Source Type: news

Shortage of treatment for highly contagious itchy skin condition caused by tiny mites poses 'significant threat' to public health, UK health leaders warn
A shortage of key medications that treat scabies a highly contagious skin condition is a major threat senior UK dermatologists warn as they urge the Government to act to boost supplies.
Source: the Mail online | Health - September 20, 2023 Category: Consumer Health News Source Type: news

FDA refuses to okay first nasal spray for allergic reactions, firm says
It would have been the first needle-free treatment for serious allergic reactions triggered by certain foods, insect stings and medications.
Source: Washington Post: To Your Health - September 20, 2023 Category: Consumer Health News Authors: Laurie McGinley Source Type: news

ClinVar Partners with ClinGen to Review & Curate Submitted Records
Do you currently use or submit clinical variation data? NCBI now has a new mechanism to improve ClinVar data quality. Since ClinVar’s founding over 10 years ago, the amount of information in this free resource has expanded dramatically with submissions from research and clinical laboratories all over the world. Because of the large volume of … Continue reading ClinVar Partners with ClinGen to Review & Curate Submitted Records →
Source: NCBI Insights - September 20, 2023 Category: Databases & Libraries Authors: NCBI Staff Tags: What's New ClinVar Source Type: news

SAS doctors in England to hold indicative ballot on strike action
Specialist, associate specialist and specialty (SAS) doctors in England could join their junior doctor and consultant colleagues on the picket line after voting to hold an indicative ballot on industrial action.
Source: GP Online News - September 20, 2023 Category: Primary Care Tags: News Source Type: news

Recovery Watch: NHSE will struggle to modernise the Lowry outpatient model
Recovering services from the covid crisis is the big task for NHS leaders for the foreseeable future. The Recovery Watch newsletter tracks prospects and progress. This week by HSJ bureau chief James Illman.
Source: HSJ - September 20, 2023 Category: UK Health Source Type: news

NLM Technical Bulletin, Sep-Oct 2023, NLM Webinar: Revolutionizing Biological Research with the NIH Comparative Genomics Resource
Comparative genomics analyses are a powerful tool for scientific discovery. The National Institutes of Health (NIH) Comparative Genomics Resource (CGR) is a freely accessible online suite of tools and data supporting comparative genomics analysis of eukaryotic organisms. The NIH-funded, multi-year project ’s vision is to maximize the biomedical impact of eukaryotic research organisms and their genomic data resources to meet emerging research needs for human health.
Source: NLM Technical Bulletin - September 20, 2023 Category: Databases & Libraries Source Type: news

'I'll inject you right now!': Channel 4 show exposes how easy it is to get hold of Ozempic with private clinics offering breakthrough weight loss jab without proper checks
An array of private clinics in London offered to dish out diabetes drug Ozempic - which has been shown to help users lose up to 33lbs - without proper health checks.
Source: the Mail online | Health - September 20, 2023 Category: Consumer Health News Source Type: news

Three common Covid symptoms doctor warns to watch out for after surge in cases
The latest data suggests that Covid cases surged by 29 percent in England in the first week of September.
Source: Daily Express - Health - September 20, 2023 Category: Consumer Health News Source Type: news

What Psychedelics Can Teach Us About Play
We are in the midst of a new psychedelic renaissance. Drugs like MDMA and psilocybin are being ushered into mainstream medicine, promoted as miracle cures for a host of psychiatric woes. But as psychedelics come to be seen as treatments for various types of psychological suffering, we are overlooking one of their most precious offerings: the potential for play. “Neuroplasticity” is the word many mental health professionals are now using to describe the positive effect of psychedelics; a process in which the brain sort of loosens up, becoming flexible and open to learning (Children’s brains, for instanc...
Source: TIME: Health - September 20, 2023 Category: Consumer Health News Authors: Ross Ellenhorn Tags: Uncategorized freelance Source Type: news

FDA Rejects Nasal Spray For Severe Allergic Reactions —Delaying First Needle-Free EpiPen Alternative
ARS Pharmaceuticals chief executive Richard Lowenthal said the company is “very surprised” and “deeply disappointed” by the FDA’s decision.
Source: Forbes.com Healthcare News - September 20, 2023 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news topline Source Type: news

Alzheimer's warning signs revealed as former London Mayor Ken Livingstone's diagnosis is announced
Former London Mayor Ken Livingstone, 78, has been diagnosed with Alzheimer's and is being cared for by his friends and family. The disease causes anxiety, memory loss and confusion.
Source: the Mail online | Health - September 20, 2023 Category: Consumer Health News Source Type: news

The Man Who Thinks He Can Live Forever
In a neat little neighborhood in Venice, Calif., there’s a block of squat, similar homes, filled with mortals spending their finite days on the planet eating pizza with friends, blowing out candles on birthday cakes, and binging late-night television. Halfway down the street, there’s a cavernous black modern box. This is where Bryan Johnson is working on what he calls “the most significant revolution in the history of Homo sapiens.”  [time-brightcove not-tgx=”true”] Johnson, 46, is a centimillionaire tech entrepreneur who has spent most of the last three years in pursuit of a si...
Source: TIME: Health - September 20, 2023 Category: Consumer Health News Authors: Charlotte Alter Tags: Uncategorized feature Source Type: news

FDA declines to approve first needle-free option to EpiPen
Federal regulators have declined to approve the first needle-free epinephrine treatment for people who suffer from severe allergic reactions, requesting its developer, ARS Pharmaceuticals, to conduct further testing.
Source: Health News - UPI.com - September 20, 2023 Category: Consumer Health News Source Type: news

One of the world's top hormone experts is suspended for gaining illicit access to confidential medical records of more than 100 patients being held by a competitor
Dr Marion Gluck, 73, known globally for her pioneering treatment of hormonal imbalances, asked another doctor for the sensitive log-in information 'as a favour'.
Source: the Mail online | Health - September 20, 2023 Category: Consumer Health News Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20